Ozempic Lawsuits Surge as Thousands Claim Blindness, Stomach Paralysis and Severe Health Risks
Nikhil Prasad Fact checked by:Thailand Medical News Team Aug 25, 2025 12 hours, 35 minutes ago
Medical News: Growing Lawsuits Against Novo Nordisk
Ozempic, the blockbuster drug made by Novo Nordisk and originally designed to help people with type 2 diabetes manage their blood sugar, is now facing a massive wave of lawsuits in the United States. More than 1,800 patients have already filed cases, with damages sought estimated to exceed 2 billion dollars.
Ozempic Lawsuits Surge as Thousands Claim Blindness, Stomach Paralysis and Severe Health Risks
The drug, which quickly gained worldwide popularity because of its weight-loss effects, is now accused of causing serious and sometimes life-altering side effects. This
Medical News report highlights the growing concerns, legal battles, and medical warnings tied to the use of Ozempic and other similar drugs.
The lawsuits have been consolidated under MDL No. 3094 in the Eastern District of Pennsylvania, which means the cases will be grouped together in federal court to speed up the legal process.
https://www.paed.uscourts.gov/mdl/mdl-3094-re-glucagon-peptide-1-receptor-agonists-glp-1-ras-products-liability-litigation
https://www.paed.uscourts.gov/search/node/Ozempic
Other similar drugs such as Wegovy and Rybelsus (also made by Novo Nordisk), along with Mounjaro and Trulicity (manufactured by Eli Lilly), are also being investigated. Experts warn that the scale of the litigation could grow even further in the coming months, with hundreds of new cases expected to be filed.
Alleged Health Complications
The central claim in these lawsuits is that the companies failed to properly warn patients and doctors about the dangerous side effects of these drugs. The most serious injuries reported include:
-Blindness and sudden vision loss linked to Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
-Gastroparesis, also known as stomach paralysis, which makes it hard for the stomach to empty food properly
-Intestinal blockages and persistent vomiting
-Gallbladder inflammation and gallstones
-Pancreatitis (inflammation of the pancreas)
-Kidney damage
-Severe dehydration and ongoing digestive problems
These conditions have left many patients struggling with permanent disabilities, long-term pain, and expensive medical treatments. Some victims allege that even after they stopped taking the drug, the damage was irreversible.
Financial Stakes and Legal Implications
Lawyers representing the plaintiffs believe the financial exposure for Novo Nordisk and Eli Lilly could surpass 2 billion dollars, especially when including punitive damages for
corporate misconduct. Compensation being sought includes medical costs, lost wages, emotional distress, and long-term pain and suffering. Analysts say the scale of this litigation could make it one of the most significant pharmaceutical lawsuits in recent decades.
Patients looking to file claims are being told that eligibility usually depends on whether they were prescribed Ozempic, Wegovy, Rybelsus, or Mounjaro, and later developed complications such as vision loss, stomach paralysis, or gallbladder disease. Medical records confirming the diagnosis and treatment are often required to support these claims.
The Role of Hollywood and Celebrity Endorsements
Adding fuel to the controversy is the widespread promotion of Ozempic in celebrity circles. Famous figures like Fat Joe, Tracy Morgan, and Kandi Burruss have publicly admitted to using the drug, while singer Macy Gray shared that she experienced severe constipation from it. Health experts warn that this Hollywood-driven popularity has led to shortages of the drug, making it harder for diabetic patients who actually need it to get prescriptions.
Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital in Boston, has spoken out strongly against the misuse of these drugs, noting that they were intended to help people with life-threatening obesity or diabetes, not as a quick fix for minor weight loss.
Conclusion
The lawsuits against Novo Nordisk and Eli Lilly are still in the early stages, with initial trials expected in 2026. While the companies continue to deny wrongdoing and argue that Ozempic is safe when used as prescribed, patients’ testimonies paint a very different picture. If proven true, these cases could reveal serious shortcomings in how pharmaceutical companies communicate risks to consumers. Beyond the billions in potential payouts, the cases raise important ethical questions about aggressive marketing, celebrity influence, and whether lifesaving drugs are being misused at the cost of public safety. For patients already affected, the struggle is not only about money but about accountability and recognition of the suffering endured.
For more details, visit:
https://lawsuittracker.org/dangerous-drugs/ozempic-lawsuit/
For the latest on Ozempic, Wegovy, Mounjaro and Trulicity, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/scientists-from-washington-university-warns-of-new-risks-discovered-with-usage-ozempic-and-wegovy
https://www.thailandmedical.news/news/overpriced-designer-semaglutide-weight-loss-drugs-like-ozempic-and-wegovy-can-cause-permanent-blindless
https://www.thailandmedical.news/news/canadian-scientists-alarmingly-find-that-weight-loss-drugs-ozempic-and-wegovy-cause-heart-muscles-to-shrink
Share
Tweet
Share
